ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q2SCImago #7,209Gold OA

FASEB BioAdvances

Identifier (ISSN):2573-9832(Print)
•
Publisher:Wiley
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
2.4↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for FASEB BioAdvances

WoS Q3
12342.720232.52024220252.42026
Annual Impact Factor Metric
Current (2026):2.4
Scopus SJR & RankScopus Q2
0.776
#7,209

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
26

26 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
101articles/year
100% Gold OA•94% Original Research

Aims & Scope

FASEB BioAdvances (ISSN: 2573-9832) is a peer-reviewed international scholarly journal in the field of Multiple, published by Wiley in United States. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.776 (Q2), an H-index of 26.

Topics Covered (Recognized by AI)
Biology68.7%Medicine66.1%Genetics58.6%Chemistry57.2%Internal medicine56.3%Biochemistry56%Gene36.2%Cell biology33.6%Computer science30.5%Endocrinology29.9%Pathology29.3%Psychology23.9%Physics21.8%Immunology21.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q3
Rank244/328
IndexESCI
JCRESCI2026

CELL BIOLOGY

Q4
Rank161/207
IndexESCI
JCIESCI2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q4
Rank269/328
IndexESCI
JCIESCI2026

CELL BIOLOGY

Q4
Rank166/207
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

9 year
2026Latest
IF2.4
Articles / Year80
Total Citations35
2025
IF2
Articles / Year98
Total Citations197
2024
IF2.5
Articles / Year62
Total Citations264
2023
IF2.7
Articles / Year50
Total Citations350
2022
IF—
Articles / Year59
Total Citations426

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,209Scopus Q2SCImago Profile
Scopus Coverage:2019-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular Biology
Scopus Citation Rank (SJR)Q2
0.776

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.31

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,154 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations359
3-Year Documents145
Citable Documents141

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q2
Molecular MedicineQ2
PhysiologyQ2
Cancer ResearchQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Biology
Minor Category (Specific Field):
4区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

FASEB BioAdvances (ISSN: 2573-9832) is a peer-reviewed international scholarly journal in the field of Multiple, published by Wiley in United States. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.776 (Q2), an H-index of 26.

The journal enforces rigorous peer evaluation with an annual output of approximately 101 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,154 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Wiley
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f09a45e8-2381-429f-bd08-cfa2a1fbd9fe
Database Updated: 2026-10-01